Cardiogenesis, CryoLife deal

CryoLife will acquire Cardiogenesis for $0.46 per share, or about $22 million in cash. The price is a 43% premium to Cardiogenesis' close of $0.32 on March 28, before the deal was announced. The deal, which has been approved by the boards of both companies, is expected to close next month. ...